PTHrP contributes to the anti-proliferative and integrin α6β4-regulating effects of 1,25-dihydroxyvitamin D3

Steroids

Volumn 72, Issue 14, 2007, Pages 930-938

  Shen, Xiaoli ^a   Mula, Ramanjaneya V R ^a   Li, Jing ^a   Weigel, Nancy L ^b   Falzon, Miriam ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

1,25 Dihydroxyvitamin D; Integrin 6 4; Prostate cancer; PTHrP

Indexed keywords

ALPHA6 INTEGRIN; ALPHA6BETA4 INTEGRIN; BETA4 INTEGRIN; CALCITRIOL; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; UPREGULATION; VITAMIN D RESPONSIVE ELEMENT;

CALCITRIOL; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; INTEGRIN ALPHA6BETA4; PARATHYROID HORMONE-RELATED PROTEIN; RNA, MESSENGER; UP-REGULATION;

EID: 35349030234     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.08.003     Document Type: Article

References (51)

1. Penson D.F., and Chan J.M. The urological diseases in America project. Prostate Cancer J Urol 177 (2007) 2020-2029
2. Bubendorf L., Schopfer A., Wagner U., Sauter G., Moch H., Willi N., et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31 (2000) 578-583
3. Steiner M.S. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J Urol 153 (1995) 1085-1096
4. Strewler G.I. Mechanisms of disease: the physiology of parathyroid hormone-related protein. New Engl J Med 342 (2000) 177-185
5. Iwamura M., Wu R., Abrahamsson P.A., di Sant'Agnese P.A., Cockett A.T., and Deftos L.J. Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells. Urology 43 (1994) 667-674
6. Kramer S., Reynolds Jr. F.J., Castillo M., Valenzuela D.M., Thorikay M., and Sorvillo J.M. Immunological identification and distribution of parathyroid hormone-like protein polypeptides in normal and malignant tissues. Endocrinology 128 (1991) 1927-1937
7. Cramer S.D., Peehl D.M., Edgar M.G., Wong S.T., Deftos L.J., and Feldman D. Parathyroid hormone-related protein (PTHrP) is an epidermal growth factor-regulated product of human prostate epithelial cells. Prostate 29 (1996) 20-29
8. Wu G., Iwamura M., di Sant'Agnese P.A., Deftos L.J., Cockett A.T.K., and Gershagen S. characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue. Urology 51 (1995) 110-120
9. Iwamura M., Gershagen S., Lapets O., Moynes R., Abrahamsson P.A., Cockett A.T., et al. Immunohostochemical localization of parathyroid hormone-related protein in prostatic intraepithelial neoplasia. Hum Pathol 26 (1995) 797-801
10. Asadi F., Farraj M., Sharifi R., Malakouti S., Antar S., and Kukreja S. Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia. Hum Pathol 27 (1996) 1319-1323
11. Rabbani S.A., Gladu J., Harakidas P., Jamison B., and Goltzman D. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo. Int J Cancer 80 (1999) 257-264
12. Deftos L.J. Prostate carcinoma: production of bioactive factors. Cancer 88 (2000) 3002-3008
13. Feldman D., Skowronski R.J., and Peehl D.M. Vitamin D and prostate cancer. Adv Exp Med Biol 375 (1995) 53-63
14. 3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 138 (1997) 1491-1497
15. 3 in the human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 139 (1998) 1197-1207
16. Tovar V.A., and Falzon M. Regulation of PTH-related protein gene expression by vitamin D in PC-3 prostate cancer cells. Mol Cell Endocrinol 190 (2002) 115-124
17. Iwamura M., Abrahamsson P.A., Foss K.A., Wu G., Cockett A.T., and Deftos L.J. Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. Urology 43 (1994) 675-679
18. Tovar V.A., and Falzon M. Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways. Reg Peptides 105 (2002) 109-120
19. Thalmann G.N., Anezinis P.E., Chang S.M., Zhau H.E., Kim E.E., Hopwood V.L., et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54 (1994) 2577-2581
20. Hall C.L., Bafico A., Dia J., Aaronson S.A., and Keller E.T. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 65 (2005) 7554-7560
21. Shen X., and Falzon M. PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile. Mol Cell Endocrinol 199 (2003) 165-177
22. Shen X., and Falzon M. PTH-related protein enhances LoVo colon cancer cell proliferation, adhesion, and integrin expression. Reg Peptides 125 (2005) 17-27
23. Shen X., and Falzon M. PTH-related protein upregulates integrin α6β4 expression and activates Akt in breast cancer cells. Exp Cell Res 312 (2006) 3822-3834
24. Rabinovitz I., and Mercurio A.M. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol 139 (1997) 1873-1884
25. Chung J., Bachelder R.E., Lipscomb E.A., Shaw L.M., and Mercurio A.M. Integrin alpha6beta4 regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 158 (2002) 165-174
26. 3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol 164 (2000) 133-143
27. Eskes R., Desagher S., Antonsson B., and Martinou J.-C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20 (2000) 929-935
28. Potts A.J., Croall D.E., and Hemler M.E. Proteolytic cleavage of the integrin β4 subunit. Exp Cell Res 212 (1994) 9
29. Strunck E., and Vollmer G. Variants of integrin β4 subunit in human endometrial adenocarcinoma cells: mediators of ECM-induced differentiation. Biochem Cell Biol 74 (1996) 867-873
30. Nishishita T., Okazaki T., Ishikawa T., Igarashi T., Hata K., Ogata E., et al. A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D. J Biol Chem 273 (1998) 10901-10907
31. Tovar V.A., and Falzon M. Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE. Mol Cell Endocrinol 204 (2003) 51-64
32. Tovar V.A., Weigel N.L., and Falzon M. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Steroids 71 (2006) 102-115
33. Sutton A.L., and MacDonald P.N. Vitamin D: more than a 'bone-a-fide' hormone. Mol Endocrinol 17 (2003) 777-791
34. Krishnan A.V., Peehl D.M., and Feldman D. Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression. J Cell Biochem 88 (2003) 363-371
35. Stewart L.V., and Weigel N.L. Vitamin D and prostate cancer. Exp Biol Med (Maywood) 229 (2004) 277-284
36. Moreno J., Krishnan A.V., Peehl D.M., and Feldman D. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway. Anticancer Res 26 (2006) 2525-2530
37. Zhang Y., Zhang J., and Studzinski G.P. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. Cell Cycle 5 (2006) 447-451
38. Falzon M., and Du P. Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide. Endocrinology 141 (2000) 1882-1892
39. Ruoslahti E., Noble N.A., Kagami S., and Border W.A. Integrins Kidney Int 45 Suppl 44 (1994) S17-S22
40. Lipscomb E.A., and Mercurio A.M. Mobilization and activation of a signaling component α6β4 integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev 24 (2005) 413-423
41. Mercurio A.M., and Rabinovitz I. Towards a mechanistic understanding of tumor-invasion-lessons from the alpha6beta4 integrin. Semin Cancer Biol 11 (2001) 129-141
42. Bonaccorsi L., Carloni V., Muratori M., Salvadori A., Giannini A., Carini M., et al. Androgen receptor expression in prostate carcinoma cells suppresses α6β4 integrin-mediated invasive phenotype. Endocrinology 141 (2000) 3172-3182
43. Maniero F., Murgia C., Wary K.K., Curatola A.M., Pepe A., Blumemberg M., et al. The coupling of α6β4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J 16 (1997) 2365-2375
44. Maniero F., Pepe A., Wary K.K., Spinardi L., Mohammadi M., Schlessinger J., et al. Signal transduction of the α6β4 integrin: distinct β4 subunit sites mediate recruitment of the Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J 14 (1995) 4470-4481
45. Guo W., Pylayeva Y., Pepe A., Yoshioka T., Muller W.J., Inghirami G., et al. β4 Integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126 (2006) 489-502
46. Murillo H., Schmidt L.J., and Tindall D.J. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2. Cancer Res 61 (2001) 7408-7412
47. Stewart L.V., Lyles B., Lin M.-F., Weigel N.L., and Vitamin. D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells. Steroid Biochem Mol Biol 97 (2005) 37-46
48. Roudier M.P., Corey E., True L.D., Hiagno C.S., Ott S.M., and Vessell R.L. Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases. Cancer Treat Res 18 (2004) 311-339
49. Hall C.L., Kang S., MacDougals O.A., and Keller E.T. Role of Wnts in prostate cancer bone metastases. J Cell Biochem 97 (2006) 661-672
50. Guise T.A. Molecular mechanisms of osteolytic bone metastases. Cancer 88 Suppl (2000) 2892-2898
51. Shaw L.M., Rabinovitz I., Wang H.H.-F., Toker A., and Mercurio A.M. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell 91 (1997) 949-960